No description available.

Master of Science / Department of Anatomy and Physiology / Mark L. Weiss / When mouse embryonic stem cells (ESCs) were grown on mitotically inactivated rat umbilical cord-derived stromal cells (RUCs) in the absence of leukemia inhibitory factor (LIF) and 2-mercaptoethanol (2-MCE), the ESCs showed alkaline phosphatase (AP) staining. ESCs cultured on RUCs maintain expression of the following pluripotency genes, Nanog, Sox2 and Oct4 and grow at a slower rate when compared with ESCs grown on mitotically inactivated mouse embryonic fibroblasts (MEFs). Differences in gene expression for the markers of pluripotency Oct4, Sox2 and Nanog, AP staining and ESC growth rate were also observed after LIF and 2-MCE were removed from the co-cultures. Reverse transcriptase polymerase chain reaction (RT-PCR) suggested differences in Sox2 and Nanog mRNA expression, with both genes being expressed at higher levels in the ESCs cultured on RUCs in the absence of LIF/2-MCE as compared to ESCs cultured on MEFs. Semi-quantitative RT-PCR indicated that Nanog expression was higher when ESCs were grown on RUCs in the absence of LIF and 2-MCE as compared to MEFs in the same treatment conditions. Bisulfite-mediated methylation analysis of the Nanog proximal promoter suggested that the maintenance of Nanog gene expression found in ESCs grown on RUCs after culture for 96 hours in the absence of LIF/2-MCE may be due to prevention of methylation of the CpG dinucleotides in the Nanog proximal promoter as compared to ESCs grown on MEFs. Thus, RUCs may release factors into the medium that maintain the pluripotent state of mouse ESCs in the absence of LIF and 2-MCE.

The mRNA cap added to the 5’ end of nascent transcripts is required for the efficient gene expression in eukaryotes. In vertebrates, the guanosine cap is methylated at N7 position by RNMT, which is in complex with its activating subunit RAM. Additionally, the first and second transcribed nucleotides can be methylated at ribose O2 position by CMTR1 and CMTR2 respectively. The mRNA cap protects transcripts from degradation and recruits cap-binding factors to promote pre-mRNA processing, nuclear export and translation initiation. In mouse embryonic stem cells (mESCs), high levels of RAM maintain expression of pluripotency factors. Differentiation of mESCs to neural progenitors is accompanied by a suppression of RAM, resulting in downregulation of pluripotency factors and efficient formation of neural cells. Here, I demonstrated that the suppression of RAM during neural differentiation is promoted via ubiquitination and proteasomal degradation. Concurrently, neural differentiation is associated with an increase in CMTR1 expression, creating a developmental cap methyltransferase switch. Moreover, differentiation into endodermal and mesodermal lineages exhibited distinct changes in the mRNA capping enzymes expression. In mESCs, RAM promotes expression of translation-associated proteins and promotes global loading of mRNA on ribosomes. RAM contributes to the ESC-specific gene expression program, by maintaining optimal expression of pluripotency-associated transcripts and inhibiting expression of neural genes. Chromatin immunoprecipitation revealed that RAM, RNMT and CMTR1 promote binding of RNA polymerase II at gene loci. In RAM-repressed cells, RNA polymerase II binding was reduced at pluripotency-associated genes, but relatively increased at neural genes. Moreover, knock-down of RNMT or CMTR1 induced increased or decreased accumulation of RNA polymerase II at promoter proximal regions respectively. In naïve T cells, Rnmt or Cmtr1 conditional knock-outs caused downregulation of translation-related transcripts and upregulation of cell cycle transcripts. Furthermore, many transcripts were specifically dependent on RNMT or CMTR1 for expression, demonstrating distinct roles of these cap methyltransferases. Thus, the mRNA cap methylation emerges as an important regulator of pluripotency and differentiation, modulating gene expression at transcriptional and post-transcriptional levels.

During the process of cloning using nuclear transfer, epigenetic marks in cells must go through a reprogramming process, so that embryonic development can occur appropriately. However, during TN this reprogramming process is not completely efficient. Analysis of cell viability and expression of genes related to pluripotency and epigenetic changes, allowed us to evaluate the action of demethylation drugs such as Procaine and SAH in somatic cell cultures. These substances are potencial inducers of epigenetic reprogramming and they could be used to improve the process of cloning by TN. The bovine fibroblasts treated with 1 mM Procaine had lower cell viability compared to the control group (non trated), while the group treated with 2 mM of SAH did not differ from the controls. OCT4 and NANOG genes were detected in control group as well as in the group treated with 1mM Procaine, while HDAC2 and DNMT1 genes were expressed in cells treated with 1 mM of Procaine as in those treated with 2 mM of SAH, showing no significant difference between the experimental groups. In this study we concluded that the OCT4 and NANOG genes are not molecular markers for cellular pluripotency in bovines and we can modify the epigenetic patterns of DNA of the nucleus donor cells for cloning by TN process, contributing to the improving of the results of this technique. / Durante o processo de clonagem por transferência nuclear, as marcas epigenéticas existentes nas células devem sofrer um processo de reprogramação, para que o desenvolvimento embrionário ocorra de forma correta, porém, essa reprogramação não é completamente eficaz. Assim, a utilização de substâncias desmetilantes, como a Procaína e SAH, podem ser de grande valia para facilitar essa reprogramação. Ao avaliar a viabilidade celular e a expressão de genes relacionados à pluripotência e alterações epigenéticas, nos permitiu verificar a atuação de drogas desmetilantes como a Procaína e a SAH em cultivo de células somáticas. Essas drogas podem auxiliar a desprogramação epigenética e serem úteis para uma melhoria do processo de clonagem por TN. Os fibroblastos bovinos tratados com 1mM de Procaína apresentaram menor viabilidade celular em relação ao grupo não tratado (controle), enquanto que as células tratadas com 2mM de SAH não apresentaram diferença em sua viabilidade entre os grupos experimentais. Os genes OCT4 e NANOG foram detectados tanto nas células controle como nas tratadas com 1mM de Procaína. Os genes HDAC2 e DNMT1 foram detectados nos mesmos níveis, tanto nas células tratadas com 1mM de Procaína quanto nas tratadas com 2mM de SAH. Com os resultados obtidos nesse estudo, concluímos que os genes OCT4 e NANOG não são marcadores moleculares para pluripotência celular em bovinos e que com possíveis modificações no cultivo celular, podemos alterar os padrões epigenéticos do DNA das células doadoras de núcleo para a clonagem por TN, contribuindo para o incremento dos resultados da técnica. / Mestre em Ciências Veterinárias